Selected presentations from the ALS Canada 2017 Virtual Research Forum held in August 2017 are now available for on-demand viewing below. The purpose of the forum was to share information about ALS/MND research with people living with the disease. 

Biomarkers for C9ORF72-associated ALS presented by Dr. Tania Gendron, Mayo Clinic

Cannabinoid use in ALS presented by Dr. Mark Ware, McGill University

Cognition in ALS – it’s not what you think presented by Dr. Michael Strong, Western University

Getting to know pimozide in ALS presented by Dr. Lawrence Korngut, University of Calgary

Lazarus by Lunasin? Untangling an ALS X-file presented by Dr. Richard Bedlack, Duke University

Masitinib for the treatment of ALS presented by AB Science

Protein misfolding in ALS presented by Dr. Neil Cashman, Vancouver Coastal Health ALS Clinic; University of British Columbia

Skin models for the study of ALS presented by Bastien Paré, Laval University

The role of ataxin-2 in ALS presented by Lindsay Becker, Stanford University

Understanding the role of the neuromuscular junction in ALS presented by Elsa Tremblay, Université de Montréal

Or read more here:




Subscribe to news and updates